September 2026
Added to Dediabetes Sep 9, 2026RCTs
This study evaluated the efficacy and safety of anagliptin in patients with type 2 diabetes who were inadequately controlled on insulin and metformin, finding a significant reduction in HbA1c levels.
Interventions
Anagliptin 100 mg twice daily
Outcomes
BMIBlood glucoseBody weight+6 more
Added to Dediabetes Sep 9, 2026RCTs
The study investigated METS-IR as a predictive biomarker for cardiovascular risk in patients with type 2 diabetes, finding significant associations with various adverse outcomes.
Interventions
METS-IR monitoring
Outcomes
All-cause mortalityCardiovascular deathIncidence heart disease+2 more
Added to Dediabetes Sep 9, 2026RCTs
This study evaluated the effectiveness of an Information-Motivation-Behavioral Skills (IMB) model-based nursing intervention for gestational diabetes. The IMB intervention significantly improved several health outcomes compared to traditional health education.
Interventions
Lifestyle intervention for prediabetes
Outcomes
Emergency cesarean section rateFasting Plasma Glucose (FPG)HbA1c+3 more
Added to Dediabetes Sep 9, 2026RCTs
This study evaluated the effectiveness of antibiotic prophylaxis using amoxicillin versus placebo in controlled type 2 diabetics undergoing dental extraction, finding no significant differences in most outcomes.
Outcomes
Alveolar osteitisAnalgesics takenDelayed healing+6 more
Added to Dediabetes Sep 9, 2026RCTs
This study evaluated a community health worker-led health literacy intervention aimed at improving adherence to lifestyle changes and medication in diabetes and hypertension patients in Harare, Zimbabwe.
Interventions
CHW-led health literacy intervention
Outcomes
Adherence to Mediterranean diet measured using MEDAS-14Adherence to alcohol moderationAdherence to non-smoking+7 more
Added to Dediabetes Sep 10, 2026RCTs
This study investigated the impact of vitamin C supplementation on inflammation in adults with metabolic syndrome, finding significant improvements in vitamin C status and metabolic markers.
Interventions
Micronutrient formula containing 1000 mg/d vitamin C
Outcomes
C-reactive proteinF2 isoprostanesFasting Plasma Glucose (FPG)+6 more
Added to Dediabetes Sep 9, 2026RCTs
This study evaluated the impact of intermittently scanned continuous glucose monitoring (isCGM) on glycemic control and fear of hypoglycemia in adults with newly diagnosed type 1 diabetes.
Interventions
Continuous glucose monitoring
Outcomes
Fear of hypoglycemia (worry)Percentage of time spent below 70 mg/dLPre-meal mean glucose+1 more
Added to Dediabetes Sep 9, 2026RCTs
This study evaluated the impact of adding SGLT2 inhibitors to basal bolus therapy in hospitalized patients with type 2 diabetes, finding improved glycemic control.
Interventions
Basal bolus therapyBasal bolus therapy with empagliflozin
Outcomes
Change in ketone body levels after combination therapyDaily glucose averageTime above range+3 more
Added to Dediabetes Sep 9, 2026RCTs
This study investigated the effects of Dapagliflozin on lipid profiles and insulin resistance in patients with Type 2 Diabetes and heart failure, finding significant improvements in various metabolic markers.
Interventions
Dapagliflozin 10 mg/day
Outcomes
BMIFasting Plasma Glucose (FPG)Fasting insulin levels+9 more
Added to Dediabetes Sep 9, 2026RCTs
The PAIGE2 Study evaluated a multicomponent lifestyle intervention for women with gestational diabetes, finding a mean weight change of -2.0 kg in the intervention group compared to -0.6 kg in the control group.
Interventions
Lifestyle intervention for prediabetes
Outcomes
BMIFasting Plasma Glucose (FPG)Waist circumference+1 more